•This screening test is ideal for expectant mothers who have become pregnant spontaneously or through
Assisted Reproductive Technology Treatments.
• Expectant mothers with advanced maternal age may be prone to developing chromosomal abnormalities (women over 35 years of age).
• Expectant mothers who wish to discover their baby’s gender as early as the 10th gestational week.
•Patients who have undergone an Assisted Reproduction Treatment without the screening of a Preimplantation Genetic Testing for aneuploidies (PGT-A).
•
At Ingenes, the Clarix test can be used with singleton and twin pregnancies.